CTS Corp Q3 sales edge past estimates on transportation segment growth
CTS•CTS Corp’s Q3 sales rose 5% to $149.6 million, slightly above the $149.12 million estimate, while adjusted EPS of $0.77 beat the $0.65 consensus. The company raised its 2026 sales and adjusted diluted EPS guidance.
1. Quarterly results
CTS Corp reported Q3 sales of $149.6 million, up 5% and slightly above the $149.12 million estimate. Adjusted EPS was $0.77, compared with the $0.65 consensus, and net income was $17.8 million.
2. Raised 2026 outlook
The company raised its 2026 sales guidance to $580 million-$590 million from $565 million-$585 million, and lifted its adjusted diluted EPS outlook to $2.78-$2.88 from $2.55-$2.70.
3. Sales by end-market
Sales to diversified end-markets grew 7% and represented 60% of total sales. Transportation sales rose 2% from a year earlier, while the company said the Millar acquisition advanced its diversification strategy, especially in the medical end-market.
